Form 8-K - Current report:
SEC Accession No. 0001558370-24-006451
Filing Date
2024-05-02
Accepted
2024-05-02 07:09:51
Documents
14
Period of Report
2024-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmc-20240502x8k.htm   iXBRL 8-K 33839
2 EX-99.1 bpmc-20240502xex99d1.htm EX-99.1 96170
  Complete submission text file 0001558370-24-006451.txt   258801

Data Files

Seq Description Document Type Size
3 EX-101.SCH bpmc-20240502.xsd EX-101.SCH 3162
4 EX-101.LAB bpmc-20240502_lab.xml EX-101.LAB 15240
5 EX-101.PRE bpmc-20240502_pre.xml EX-101.PRE 9839
17 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20240502x8k_htm.xml XML 4627
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37359 | Film No.: 24905244
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)